PMV — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
eTheRNAetherna.beJun 2020
Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development.
BiotechDeep TechMedical DevicesNiel, BE
Co-investorsFund+Boehringer Ingelheim Venture FundEQT Life SciencesNovalis LifeSciencesPWV
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.